Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Leukemia, Myeloid × Sirolimus × Clear all

Phase

Phase 2 3 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Lymphoma 11 Multiple Myeloma 10 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Neoplasm Metastasis 9 Leukemia 9 Neoplasms 8 Hodgkin Disease 8 Lymphoma, Non-Hodgkin 7 Carcinoma, Non-Small-Cell Lung 7 Myelodysplastic Syndromes 6 Leukemia, Myeloid, Acute 6 Carcinoma, Renal Cell 6 Breast Neoplasms 6 Recurrence 5 Melanoma 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Hematologic Neoplasms 5 Graft vs Host Disease 5 Unspecified Adult Solid Tumor, Protocol Specific 4 Prostatic Neoplasms 4 Primary Myelofibrosis 4 Pancreatic Neoplasms 4 Neoplasms, Plasma Cell 4 Leukemia, Myelomonocytic, Chronic 4 Leukemia, Myeloid, Chronic-Phase 4 Blast Crisis 4 Advanced Cancer 4 Myeloproliferative Disorders 3 Lung Neoplasms 3

Interventions

venetoclax 5 Cytarabine 4 Azacitidine 4 fludarabine 3 aldesleukin 2 RO6839921 2 Methotrexate 2 Interleukin-2 2 Granulocyte Colony-Stimulating Factor 2 Etoposide 2 Decitabine 2 Dasatinib 2 zileuton 1 thymoglobulin 1 spartalizumab 1 sabatolimab 1 quizartinib 1 pulrodemstat besilate 1 posaconazole 1 plerixafor 1 gilteritinib 1 fludarabine phosphate 1 etoposide phosphate 1 emvododstat 1 daratumumab 1 blinatumomab 1 Sorafenib 1 Sirolimus 1 Panobinostat 1 N-((5-bromo-2-thienyl)sulfonyl)-2,4-dichlorobenzamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00780104 2019-07-12

UPCC 02407

Abramson Cancer Center at Penn Medicine

Phase 1 Completed

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡